Guidance
Skip Standards and indicators submenu
Quality standards
Our quality standards set out priority areas for quality improvement. They highlight areas with identified variation in current practice.
View our quality standards
How to use our quality standards
The timeline for developing quality standards
Help us develop quality standards
Selecting and prioritising quality standards topics
About quality standards
Indicators
Our indicators measure outcomes that reflect the quality of care, or processes linked by evidence to improved outcomes.
View list of indicators
Learn about the committee that develops indicators
About indicators
Skip Life sciences submenu
Life Sciences
We offer tailored support to industry during product development. Our expertise can help you build the evidence needed to achieve market access.
View life sciences
Get support from NICE
NICE Advice service
Trusted, unrivalled expertise.
Make an enquiry
Contact us to discuss your requirements.
Innovative Licensing and Access Pathway (ILAP)
Streamlining patient access to safe, financially sustainable and innovative medicines.
Learn how we evaluate technologies
Health technology evaluation and topic selection manuals
Updated manuals for methods, processes and topic selection.
Digital health technologies
Accelerating our efforts to deliver innovation to the health and care system.
Evidence standards framework
Using the best available evidence to develop recommendations that guide decisions in health, public health and social care.
Our guidance programmes
Ensuring new technologies are clinically effective and offer economic value.
Register your product
Non-pharmaceutical
NHS Innovation Service is a clear and simple point of entry for health technologies to access support and national evaluation programmes.
Pharmaceutical
UK PharmaScan is a database of new medicines, indications and formulations in the pharmaceutical pipeline.
Find published and proposed evaluations
Diagnostics
Guidance on measurements and tests used to evaluate a patient's condition.
Medical technologies
Guidance on medical technologies put forward to NICE by manufacturers.
Technology appraisals
Guidance on new and existing medicines and treatments in the NHS.
Highly specialised technologies
Guidance on the use of highly specialised medicines and treatments.
British National Formulary (BNF)
British National Formulary for Children (BNFC)
Clinical Knowledge Summaries (CKS)
Skip About submenu
About
NICE helps practitioners and commissioners get the best care to patients, fast, while ensuring value for the taxpayer.
Explore about
Our programmes
Learn about the information we produce.
Guidance
Advice
Quality standards
Indicators
Digital health
Topic selection
Get involved
Understand how decisions are made:
Attend a committee meeting
Comment on draft guidance:
Guidance in consultation
Be part of a guidance committee:
Join a committee
Help develop our products:
Register as a stakeholder
Putting you at the heart of our work:
Public involvement
What we do
Social care
Life sciences
NICE international
Patient safety
Shared decision making
Into practice
Social care quick guides
Measuring the use of NICE guidance
Resource planner
View all Into practice
Who we are
The board
The NICE strategy 2021 to 2026
Corporate publications
View all Who we are
- Contact us
- Jobs

Child maltreatment: when to suspect maltreatment in under 18s

Clinical guideline
Reference number: CG89
Published: 22 July 2009
Last updated: 09 October 2017

History

Stakeholder list updated

Stakeholder list (PDF 127 KB)

Published:

12 March 2019

Surveillance consultation

Surveillance consultation
Surveillance review proposal (online version)
Surveillance review proposal (PDF version) (PDF 277 KB)

Published:

29 November 2018

Review documents

Review proposal consultation information
Review proposal consultation document (PDF 312 KB)

Published:

13 July 2012
Stakeholder list (PDF 40 KB)

Published:

13 July 2012
Review decision (PDF 363 KB)

Published:

11 September 2012
Static list review decision (PDF 1.38 MB)

Published:

17 February 2014

Guideline consultation comments table responses

Guideline consultation comments table responses (PDF 1.79 MB)

Published:

22 July 2009

Guideline consultation

Guideline consultation information
Full guideline for consultation (PDF 757 KB)

Published:

16 December 2008
NICE guideline for consultation (PDF 171 KB)

Published:

16 December 2008
Appendix A Search strategies for consultation (PDF 885 KB)

Published:

16 December 2008
Appendix B Evidence tables for consultation (PDF 439 KB)

Published:

16 December 2008
Appendix C Excluded studies for consultation (PDF 708 KB)

Published:

16 December 2008

GDG members and minutes

GDG members and minutes
Guidance Development Group members (PDF 15 KB)

Published:

04 March 2008
GDG minutes - 6 and 7 October 2008 (PDF 1.88 MB)

Published:

22 January 2009
GDG minutes - 2 September 2008 (PDF 839 KB)

Published:

10 November 2008
GDG minutes - 16 and 17 July 2008 (PDF 1.99 MB)

Published:

16 September 2008
When to suspect maltreatment: GDG minutes - 24 June 2008 (PDF 170 KB)

Published:

18 November 2008
When to suspect maltreatment: GDG minutes - 6 and 7 May 2008 (PDF 160 KB)

Published:

18 November 2008
When to suspect maltreatment: GDG minutes - 1 April 2008 (PDF 32 KB)

Published:

18 November 2008
GDG minutes - 26 February 2008 (PDF 35 KB)

Published:

20 May 2008
GDG minutes - 22 January 2008 (PDF 33 KB)

Published:

11 March 2008
GDG minutes - 18 December 2007 (PDF 16 KB)

Published:

25 February 2008

List of stakeholders

List of stakeholders (PDF 28 KB)

Published:

07 May 2009

Scope consultation comments from stakeholders

Final scope (PDF 37 KB)

Published:

11 July 2007

Final scope

Final scope (PDF 37 KB)

Published:

11 July 2007

The guideline development process - an overview for stakeholders, the public and the NHS (third edition)

Remit

Remit (PDF 37 KB)

Published:

09 February 2006

Draft consultation scope

Draft consultation scope (PDF 104 KB)

Published:

12 December 2006